{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1146.1602","meta":{"versionId":"8","lastUpdated":"2022-01-18T01:02:46.000-05:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1602","version":"20220118","name":"HIV Infection (ARV Postattachment Inhibitors) (RXNORM)","status":"active","date":"2022-01-18T01:02:46-05:00","publisher":"CSTE Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"2043317","display":"1.33 ML ibalizumab-uiyk 150 MG/ML Injection"},{"code":"2043322","display":"1.33 ML ibalizumab-uiyk 150 MG/ML Injection [Trogarzo]"}]}]},"expansion":{"identifier":"urn:uuid:cc708cf7-1b78-42b4-ae49-90bf683e0532","timestamp":"2022-06-10T08:23:53-04:00","total":2,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2043317","display":"1.33 ML ibalizumab-uiyk 150 MG/ML Injection"},{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","code":"2043322","display":"1.33 ML ibalizumab-uiyk 150 MG/ML Injection [Trogarzo]"}]}}